Pages that link to "Q36979056"
Jump to navigation
Jump to search
The following pages link to Early detection of adverse drug events within population-based health networks: application of sequential testing methods. (Q36979056):
Displaying 50 items.
- The coming age of data-driven medicine: translational bioinformatics' next frontier (Q28386235) (← links)
- Novel data-mining methodologies for adverse drug event discovery and analysis (Q28681788) (← links)
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance (Q29031025) (← links)
- Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual (Q30588232) (← links)
- Drug safety data mining with a tree-based scan statistic (Q30604219) (← links)
- Signal detection and monitoring based on longitudinal healthcare data (Q30706851) (← links)
- A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment. (Q30812957) (← links)
- Concordance and predictive value of two adverse drug event data sets (Q30844334) (← links)
- Hospitalization for drug-induced hepatotoxicity: linking Y-codes with pharmaceutical claims data to identify implicated medicines (Q30892973) (← links)
- Methodological framework to identify possible adverse drug reactions using population-based administrative data (Q30980862) (← links)
- Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases (Q33392194) (← links)
- Medication-wide association studies (Q33633627) (← links)
- Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases (Q33723762) (← links)
- Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data (Q34133842) (← links)
- Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot (Q34133849) (← links)
- Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules (Q34135347) (← links)
- Adverse drug events with hyperkalaemia during inpatient stays: evaluation of an automated method for retrospective detection in hospital databases (Q34184832) (← links)
- Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples. (Q34226785) (← links)
- Translational bioinformatics embraces big data (Q34378848) (← links)
- Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network (Q34996701) (← links)
- Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example (Q35045666) (← links)
- Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions (Q36771112) (← links)
- Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records. (Q36771146) (← links)
- Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study (Q37319463) (← links)
- Modern methods of pharmacovigilance: detecting adverse effects of drugs (Q37626687) (← links)
- Methods for observational post-licensure medical product safety surveillance (Q37964440) (← links)
- Development of a detection algorithm for statin-induced myopathy using electronic medical records (Q38093266) (← links)
- Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel. (Q38127002) (← links)
- Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance (Q38701074) (← links)
- Methods for safety signal detection in healthcare databases: a literature review (Q38793916) (← links)
- Vaccine Case-Population: A New Method for Vaccine Safety Surveillance (Q38804897) (← links)
- Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation (Q38835088) (← links)
- Recent Literature Update on Medication Risk in Older Adults, 2015-2016. (Q38859905) (← links)
- Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database (Q40075147) (← links)
- Comparison of epidemiologic methods for active surveillance of vaccine safety (Q40094601) (← links)
- Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study (Q40261938) (← links)
- Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome (Q41226295) (← links)
- Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity (Q41528115) (← links)
- The role of national registries in improving patient safety for hip and knee replacements (Q42690863) (← links)
- Disproportionality methods for pharmacovigilance in longitudinal observational databases (Q43432728) (← links)
- Echocardiography for the Detection of Valvulopathy Associated with the Use of Ergot-Derived Dopamine Agonists in Patients with Parkinson's Disease (Q44130052) (← links)
- A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis (Q44834340) (← links)
- Impact of exposure accrual on sequential postmarket evaluations: a simulation study (Q45733534) (← links)
- A comparison of the empirical performance of methods for a risk identification system (Q46050855) (← links)
- Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study (Q47271377) (← links)
- Assessing performance of sequential analysis methods for active drug safety surveillance using observational data (Q47441653) (← links)
- The state of adverse event reporting and signal generation of dietary supplements in Korea (Q51729246) (← links)
- Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance (Q57590034) (← links)
- The impact of exposure model misspecification on signal detection in prospective pharmacovigilance (Q58159898) (← links)
- Doctors' perceptions of laboratory monitoring in office practice (Q60144193) (← links)